Juan, C.; Zamorano, L.; Mena, A.; Albertí, S.; Pérez, J.L.; Oliver, A., "Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to succesful Pseudomonas aeruginosa clones.", "Antimicrobial Agents and Chemotherapy", Volum 65, Pàgines 474-478, 2010. Article.
Racey, D.; Inglis, R.F.; Harrison, F.; Oliver, A.; Buckling, A., "The effect of elevated mutation rates on the evolution of cooperation and virulence of Pseudomonas aeruginosa.", "Evolution", 2010. Article.
Juan, C.; Zamorano, L.; Pérez, J.L.; Ge, Y.; Oliver, A., "Activity of a new antipseudomonal cephalosporin, CXA-101 (FR264205), against carbapenem-resistant and multidrug-resistant Pseudomonas aeruginosa clinical strains.", "Antimicrobial Agents and Chemotherapy", 2010. Article.
C. Juan, L. Zamorano, A. Mena, S. Albertí, J.L. Pérez,A. Oliver, "Metallo-β-lactamase (MBL)-Producing Pseudomonas putida as a Reservoir of Multidrug-Resistance Elements that Are Efficiently Amplified by Transference to Successful P. aeruginosa Clones.", "Journal of Antimicrobial Chemotherapy", Volum 65, Número 3, Pàgines 474-478, 2010. Article.
Moyá, B.; Zamorano, L.; Juan, C.; Pérez, J.L.; Ge, Y.; Oliver, A., "Activity of a new cephalosporin, CXA-101 (FR264205), against β-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of intensive care unit patients.", "Antimicrobial Agents and Chemotherapy", 2010. Article.
Zamorano, L.; Juan, C.; Fernández-Olmos, A.; Ge, Y.; Cantón, R.; Oliver, A., "Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically infected cystic fibrosis patients.", "Clinical Microbiology and Infection", 2010. Article.
Juan Nicolau, C.; Oliver, A., "Carbapenemasas en especies del género Pseudomonas", "Enfermedades Infecciosas y Microbiologia Clinica", 2010. Article.
Laura Zamorano, Bartolome? Moya? , Carlos Juan ,Antonio Oliver, "Differential b-lactam resistance response driven by ampD or dacB (PBP4) inactivation in genetically diverse Pseudomonas aeruginosa strains", "Journal of Antimicrobial Chemotherapy", Volum 65, Número 7, Pàgines 1540-1542, 2010. Article.
Rodríguez-Rojas, A.; Maciá, M.D.; Couce, A.; Gómez, C.; Castañeda-García, A.; Oliver, A.; Blázquez, J., "Assessing the emergence of resistance: the absence of biological cost in vivo may compromise fosfomycin treatments for Pseudomonas aeruginosa infections.", "Plos One", 2010. Article.
Rodríguez-Baño, J.; Picón, E.; Gijón, P.; Hernández, J.R.; Cisneros, J.M.; Peña, C.; Almela, M.; Almirante, B.; Grill, F.; Colomina, J.; Molinos, S.; Oliver, A.; Fernández-Mazarrasa, C.; Navarro, G.; Coloma, A.; López-Cerero, L.; Pascual, A., "Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.", "Journal of Clinical Microbiology", 2010. Article.
Oliver, A.; Mena, A., "Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance", "Clinical Microbiology and Infection", 2010. Article.
Moyá B; Zamorano L; Juan C; Ge ; Oliver A., "Affinity of the new cephalosporin CXA-101 to penicillin-binding proteins of Pseudomonas aeruginosa.", "Antimicrobial Agents and Chemotherapy", Volum 54, Número 9, Pàgines 3933-3937, 2010. Article.
Laura Zamorano, Thomas M. Reeve, Lehua Deng, Carlos Juan, Bartolome Moya, Gabriel Cabot,David J. Vocadlo, Brian L. Mark,Antonio Oliver, "NagZ Inactivation Prevents and Reverts -Lactam Resistance, Driven by AmpD and PBP 4 Mutations, in Pseudomonas aeruginosa", "Antimicrobial Agents and Chemotherapy", Volum 54, Número 9, Pàgines 3557-3563, 2010. Article.
Merino, M.; Pérez-Llarena, F.J.; Kerff, F.; Poza, M.; Mallo, S.; Rumbo-Feal, S.; Beceiro, A.; Juan, C.; Oliver, A.; Bou, G., "Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-{beta}-lactamases", "Journal of Antimicrobial Chemotherapy", 2010. Article.
Zhang, Y.; Bao, Q.; Gagnon, L.A.; Huletsky, A.; Oliver, A.; Jin, S.; Langaee, T., "ampG gene of Pseudomonas aeruginosa and its role in beta-lactamase expression.", "Antimicrobial Agents and Chemotherapy", 2010. Article.
Valderrey, A.; Pozuelo, M.J.; Jimenez, P.J.; Macia, M.D.; Oliver, A.; Rotger, R., "Chronic colonization by Pseudomonas aeruginsa of patients with obstructive lung diseases: cystic fibrosis, bronchiectasis and chronic obstructive pulmonary disease", "Diagnostic Microbiology and Infectious Disease", 2010. Article.
Oliver A, "Mutators in cystic fibrosis chronic lung infection: prevalence, mechanisms, and consequences for antimicrobial therapy", "International Journal of Medical Microbiology", 2010. Article.
Rodríguez-Baño, J.; Picón, E.; Gijón, P.; Hernández, J.R.; Ruíz, M.; Peña, C.; Almela, M.; Almirante, B.; Grill, F.; Colomina, J.; Giménez, M.; Oliver, A.; Horcajada, J.P.; Navarro, G.; Coloma, A.; Pascual, A, "Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis", "Clinical Infectious Diseases", 2010. Article.